These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33368072)

  • 41. Response to antiretroviral therapy after a single, peripartum dose of nevirapine.
    Lockman S; Shapiro RL; Smeaton LM; Wester C; Thior I; Stevens L; Chand F; Makhema J; Moffat C; Asmelash A; Ndase P; Arimi P; van Widenfelt E; Mazhani L; Novitsky V; Lagakos S; Essex M
    N Engl J Med; 2007 Jan; 356(2):135-47. PubMed ID: 17215531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi.
    Ioannidis JP; Taha TE; Kumwenda N; Broadhead R; Mtimavalye L; Miotti P; Yellin F; Contopoulos-Ioannidis DG; Biggar RJ
    Int J Epidemiol; 1999 Aug; 28(4):769-75. PubMed ID: 10480709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychosocial health in pregnancy and postpartum among women living with - and without HIV and non-pregnant women living with HIV living in the Nordic countries - Results from a longitudinal survey study.
    Moseholm E; Aho I; Mellgren Å; Pedersen G; Katzenstein TL; Johansen IS; Bach D; Storgaard M; Weis N
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):20. PubMed ID: 34996383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
    Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
    J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique.
    Liotta G; Mancinelli S; Nielsen-Saines K; Gennaro E; Scarcella P; Magid NA; Germano P; Jere H; Guidotti G; Buonomo E; Ciccacci F; Palombi L; Marazzi MC
    PLoS One; 2013; 8(8):e71653. PubMed ID: 23990966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of antiretroviral regimen on viral suppression among pregnant women living with HIV in Brazil.
    Pascom ARP; Fonseca FF; Pinho RGG; Perini FB; Pereira G; Avelino-Silva VI
    Int J STD AIDS; 2020 Aug; 31(9):903-910. PubMed ID: 32702281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
    Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
    AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-year viral load suppression among adolescents receiving antiretroviral therapy in the Cape Metropole, South Africa, 2013 - 2015: A retrospective cohort analysis.
    Van Wyk BE; Kriel E; Mukumbang F
    S Afr Med J; 2020 Nov; 110(12):1213-1217. PubMed ID: 33403968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir/ritonavir during pregnancy: analysis of population-based surveillance data from the national study of HIV in pregnancy and childhood in the United Kingdom and Ireland.
    Tookey PA; Thorne C; van Wyk J; Norton M
    BMC Infect Dis; 2016 Feb; 16():65. PubMed ID: 26847625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV-1 viremia during the first 28 weeks of pregnancy is not associated with mother-to-child transmission.
    Senise JF; Palacios R; Tanno ZN; Lunardi L; Waghabi GR; Vaz MJ; Diaz RS; Castelo A
    Braz J Infect Dis; 2006 Aug; 10(4):259-63. PubMed ID: 17293908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pregnancy in women diagnosed with HIV on antiretroviral therapy in Ethiopia: a retrospective cohort study.
    Elliver M; Hallström I; Jerene D
    Pan Afr Med J; 2020; 37():101. PubMed ID: 33425134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.
    Joseph O; Biodun O; Michael E
    J Coll Physicians Surg Pak; 2011 Jun; 21(6):356-9. PubMed ID: 21711992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.
    Coffey S; Bacchetti P; Sachdev D; Bacon O; Jones D; Ospina-Norvell C; Torres S; Lynch E; Camp C; Mercer-Slomoff R; Lee S; Christopoulos K; Pilcher C; Hsu L; Jin C; Scheer S; Havlir D; Gandhi M
    AIDS; 2019 Apr; 33(5):825-832. PubMed ID: 30882490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children.
    Abrams EJ; Wiener J; Carter R; Kuhn L; Palumbo P; Nesheim S; Lee F; Vink P; Bulterys M;
    AIDS; 2003 Apr; 17(6):867-77. PubMed ID: 12660534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
    Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
    BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French Perinatal Cohort.
    Mayaux MJ; Teglas JP; Blanche S;
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):338-43. PubMed ID: 14600581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virological profile of pregnant HIV positive women with high levels of CD4 count in low income settings: can viral load help as eligibility criteria for maternal triple ARV prophylaxis (WHO 2010 option B)?
    Njom Nlend AE; Same Ekobo C; Moyo ST; Nguetcheng GC; Ngang P; Lyeb S; Meka L; Baane M
    Pan Afr Med J; 2011; 10():27. PubMed ID: 22187609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
    Mandelbrot L; Tubiana R; Le Chenadec J; Dollfus C; Faye A; Pannier E; Matheron S; Khuong MA; Garrait V; Reliquet V; Devidas A; Berrebi A; Allisy C; Elleau C; Arvieux C; Rouzioux C; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Dec; 61(11):1715-25. PubMed ID: 26197844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.